A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
F cells measure the presence of fetal hemoglobin, a heritable quantitative trait in adults that accounts for substantial phenotypic diversity of sickle cell disease and beta thalassemia. We applied a genome-wide association mapping strategy to individuals with contrasting extreme trait values and mapped a new F cell quantitative trait locus to BCL11A, which encodes a zinc-finger protein, on chromosome 2p15. The 2p15 BCL11A quantitative trait locus accounts for 15.1% of the trait variance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BCL11A is a repressor of HbF gene expression.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [14]
Citations
Cites
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Population Structure and Eigenanalysis
Patterson, N., Price, A. L., & Reich, D. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020190 · Cited by 5,280
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
A General Test of Association for Quantitative Traits in Nuclear Families
Abecasis, G. R., Cardon, L. R., & Cookson, W. O. C. (2000) · The American Journal of Human Genetics · doi:10.1086/302698 · Cited by 1,126
Disorders of hemoglobin genetics, pathophysiology, and clinical management
Steinberg, M. H. (2001) · Cited by 438
Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management
Somervaille, T. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401119 · Cited by 432
Bcl11a is essential for normal lymphoid development
Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351
Thein, S. L., Menzel, S., Peng, X., Best, S., Jiang, J., Close, J., Silver, N., Gerovasilli, A., Ping, C., Yamaguchi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611393104 · Cited by 314
Self-citationGenetic influences on F cells and other hematologic variables: a twin heritability study
Garner, C., Tatu, T., Reittie, J. E., Littlewood, T., Darley, J., Cervino, S., Farrall, M., Kelly, P., Spector, T. D., & Thein, S. L. (2000) · Blood · doi:10.1182/blood.v95.1.342 · Cited by 274
Self-citationRegulation of human fetal hemoglobin: new players, new complexities
Bank, A. (2006) · Blood · doi:10.1182/blood-2005-05-2113 · Cited by 209
Cited by
Items 201–300 of 534
Disruption of the Hbs1l-Myb Locus Causes Hereditary Persistence of Fetal Hemoglobin in a Mouse Model
Suzuki, M., Yamazaki, H., Mukai, H. Y., Motohashi, H., Shi, L., Tanabe, O., Engel, J. D., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01617-12 · Cited by 40
Use of genome-editing tools to treat sickle cell disease
Tasan, I., Jain, S., & Zhao, H. (2016) · Human Genetics · doi:10.1007/s00439-016-1688-0 · Cited by 36
King, A. J., & Higgs, D. R. (2018) · Hematology · doi:10.1182/asheducation-2018.1.353 · Cited by 40
Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia
Bao, X., Zhang, X., Wang, L., Wang, Z., Huang, J., Zhang, Q., Ye, Y., Liu, Y., Chen, D., Zuo, Y., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.03.005 · Cited by 35
Genome-wide association studies of hematologic phenotypes: a window into human hematopoiesis
Sankaran, V. G., & Orkin, S. H. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.02.006 · Cited by 33
Genetic Mapping of Head Size Related Traits in Common Carp (Cyprinus carpio)
Chen, L., Peng, W., Kong, S., Pu, F., Chen, B., Zhou, Z., Feng, J., Li, X., & Xu, P. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00448 · Cited by 34
The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells
Lan, X., Khandros, E., Huang, P., Peslak, S. A., Bhardwaj, S. K., Grevet, J. D., Abdulmalik, O. Y., Wang, H., Keller, C. A., Giardine, B. M., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019032318 · Cited by 34
A unified model of human hemoglobin switching through single-cell genome editing
Shen, Y., Verboon, J. M., Zhang, Y., Liu, N., Kim, Y. J., Marglous, S., Nandakumar, S. K., Voit, R. A., Fiorini, C., Ejaz, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25298-9 · Cited by 36
Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies
Demirci, S., Leonard, A. K., & Tisdale, J. F. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa088 · Cited by 33
Five Priorities of African Genomics Research: The Next Frontier
Wonkam, A., Munung, N. S., Dandara, C., Esoh, K. K., Hanchard, N. A., & Landouré, G. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-111521-102452 · Cited by 37
Variation and heritability of Hb F and F‐cells among β‐thalassemia heterozygotes in Hong Kong
Gibney, G. T., Panhuysen, C. I. M., So, J. C. C., Ma, E. S. K., Ha, S. Y., Li, C. K., Lee, A. C. W., Li, C. K., Yuen, H. L., Lau, Y. L., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21150 · Cited by 32
Friedrisch, J. R., Sheehan, V., Flanagan, J. M., Baldan, A., Summarell, C. C. G., Bittar, C. M., Friedrisch, B. K., Wilke, I. I., Ribeiro, C. B., Daudt, L. E., et al. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.11.002 · Cited by 34
Krüppel-Like Factor 1: A Pivotal Gene Regulator in Erythropoiesis
Caria, C. A., Faà, V., & Ristaldi, M. S. (2022) · Cells · doi:10.3390/cells11193069 · Cited by 37
Targeting sickle cell disease root-cause pathophysiology with small molecules
Saunthararajah, Y. (2019) · Haematologica · doi:10.3324/haematol.2018.207530 · Cited by 32
Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials
Segura, E., Ayoub, P. G., Hart, K. L., & Kohn, D. B. (2023) · Viruses · doi:10.3390/v15030713 · Cited by 35
Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
Paschoudi, K., Yannaki, E., & Psatha, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119527 · Cited by 34
So, C. C., So, A. C. Y., Chan, A. Y. Y., Tsang, S. T. Y., Ma, E. S. K., & Chan, L. C. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.067538 · Cited by 30
A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia
Adeyemo, T. A., Ojewunmi, O. O., Oyetunji, I. A., Rooks, H., Rees, D. C., Akinsulie, A., Akanmu, S. A., Thein, S. L., & Menzel, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197927 · Cited by 31
Self-citationGenetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study
Sherva, R., Sripichai, O., Abel, K. J., Ma, Q., Whitacre, J. L., Angkachatchai, V., Makarasara, W., Winichagoon, P., Svasti, S., Fucharoen, S., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-51 · Cited by 36
CRISPR-based therapeutic genome editing for inherited blood disorders
Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 39
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy
Rosanwo, T. O., & Bauer, D. E. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.002 · Cited by 35
Liu, B., Brendel, C., Vinjamur, D. S., Zhou, Y., Harris, C. E., McGuinness, M. K., Manis, J. P., Bauer, D. E., Xu, H., & Williams, D. A. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.002 · Cited by 30
Fanis, P., Kousiappa, I., Phylactides, M., & Kleanthous, M. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-108 · Cited by 30
Diagnosis and prevention of thalassemia
Ip, H., & So, C. C. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.847236 · Cited by 30
Liu, L., Pertsemlidis, A., Ding, L.-H., Story, M. D., Steinberg, M. H., Sebastiani, P., Hoppe, C. C., Ballas, S. K., & Pace, B. S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216642047 · Cited by 33
Molecular Basis of Thalassemia
Grosso, M., Sessa, R., Puzone, S., Rosaria, M., & Izzo, P. (2012) · InTech eBooks · doi:10.5772/31362 · Cited by 34
Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option
Starlard‐Davenport, A., Gu, Q., & Pace, B. S. (2022) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-022-00589-z · Cited by 31
Fetal Hemoglobin Regulation in Beta-Thalassemia
Lu, H. Y., Orkin, S. H., & Sankaran, V. G. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.002 · Cited by 30
The genetics of hemoglobin A2 regulation in sickle cell anemia
Griffin, P. J., Sebastiani, P., Edward, H. L., Baldwin, C. T., Gladwin, M. T., Gordeuk, V. R., Chui, D. H. K., & Steinberg, M. H. (2014) · American Journal of Hematology · doi:10.1002/ajh.23811 · Cited by 31
Gallienne, A. E., Dreau, H. M.-P., McCarthy, J., Timbs, A., Hampson, J. M., Schuh, A., Old, J., & Henderson, S. J. (2009) · Hemoglobin · doi:10.3109/03630260903344564 · Cited by 28
Genomic approaches to identifying targets for treating β hemoglobinopathies
Ngo, D., & Steinberg, M. H. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0120-2 · Cited by 32
Promise of gene therapy to treat sickle cell disease
Romero, Z. G., DeWitt, M. A., & Walters, M. C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1536119 · Cited by 29
Global Genetic Architecture of an Erythroid Quantitative Trait Locus,HMIP-2
Menzel, S., Rooks, H., Zélénika, D., Nkya, S. W., Gnanakulasekaran, A., Drašar, E., Cox, S. E., Liu, L., Masood, M., Silver, N., et al. (2014) · Annals of Human Genetics · doi:10.1111/ahg.12077 · Cited by 26
Self-citationInsight of fetal to adult hemoglobin switch: Genetic modulators and therapeutic targets
Hariharan, P., & Nadkarni, A. H. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100823 · Cited by 28
Nkya, S. W., Mgaya, J., Singh, T., Mariki, H., Rooks, H., Soka, D., Mmbando, B. P., Thein, S. L., Barrett, J. C., Makani, J., et al. (2015) · BMC Medical Genetics · doi:10.1186/s12881-015-0148-3 · Cited by 28
Self-citationBarbarani, G., Fugazza, C., Strouboulis, J., & Ronchi, A. E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00091 · Cited by 27
Sales, R. R., Belisário, A. R., Faria, G., Mendes, F. G., Luizon, M. R., & Viana, M. B. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04079-2 · Cited by 32
Cai, T., Chen, X., Li, J., Xiang, B., Yang, L., Liu, Y., Chen, Q., He, Z., Sun, K., & Liu, P. (2017) · American Journal of Hematology · doi:10.1002/ajh.24902 · Cited by 26
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
Cisneros, G. S., & Thein, S. L. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000584 · Cited by 26
Self-citationBhanushali, A. A., Patra, P. K., Nair, D., Verma, H. K., & Das, B. R. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.10.003 · Cited by 26
Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease
Cui, S., & Engel, J. D. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_7 · Cited by 25
Nkya, S. W., Mwita, L. A., Mgaya, J., Kumburu, H. H., van Zwetselaar, M., Menzel, S., Mazandu, G. K., Sangeda, R. Z., Chimusa, E. R., & Makani, J. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01059-1 · Cited by 27
Self-citationPace, B. S., Liu, L., Li, Y., & Makala, L. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215596859 · Cited by 26
Bio-electrospraying whole human blood: analysing cellular viability at a molecular level
Swainson, N. M., Best, S., Aarons, E., & Jayasinghe, S. N. (2009) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.185 · Cited by 24
Self-citationFromm, G. J., & Bulger, M. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-048 · Cited by 29
Moradifard, S., Hoseinbeyki, M., Emam, M. M., Parchiniparchin, F., & Ebrahimi‐Rad, M. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108339 · Cited by 24
Demirci, S., Zeng, J., Palchaudhuri, R., Wu, C., Abraham, D. M., Hayal, T. B., Essawi, K., Nguyen, M. A., Stasula, U., Chu, R., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.10.014 · Cited by 25
Grieco, A. J., Billett, H. H., Green, N., Driscoll, M. C., & Bouhassira, E. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129431 · Cited by 25
Dai, Y., Sangerman, J., Luo, H., Fucharoen, S., Chui, D. H. K., Faller, D. V., & Perrine, S. P. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.10.004 · Cited by 26
Recent advancements in gene therapy for sickle cell disease and β-thalassemia
Li, L., & Mandal, P. K. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1468952 · Cited by 29
Pathogenic BCL11A variants provide insights into the mechanisms of human fetal hemoglobin silencing
Shen, Y., Li, R., Teichert, K., Montbleau, K. E., Verboon, J. M., Voit, R. A., & Sankaran, V. G. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009835 · Cited by 24
The future of sickle cell disease therapeutics rests in genomics
Wonkam, A. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049765 · Cited by 23
Parekh, D. S., Eaton, W. A., & Thein, S. L. (2023) · Blood · doi:10.1182/blood.2023021167 · Cited by 24
Self-citationNeishabury, M., Azarkeivan, A., & Najmabadi, H. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.10.007 · Cited by 23
Dadheech, S., Jain, S., MadhuLatha, D. M., Sharma, V., Joseph, J., Jyothy, A., & Munshi, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3195-5 · Cited by 28
Foetal haemoglobin (HbF) status in adult sickle cell anaemia patients in Ibadan, Nigeria
Olaniyi, J. A., Olaniyi, O., & Arinola, A. M. (2011) · Annals of Ibadan Postgraduate Medicine · doi:10.4314/aipm.v8i1.63955 · Cited by 23
Chan, C. M., Fulton, J., Montiel‐Duarte, C., Collins, H. M., Bharti, N., Wadelin, F. R., Moran, P. M., Mongan, N. P., & Heery, D. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt761 · Cited by 28
Chaouch, L., Moumni, I., Ouragini, H., Darragi, I., Kalai, M., Chaouachi, D., Boudrigua, I., Hafsia, R., & Abbès, S. (2015) · Hematology · doi:10.1080/10245332.2015.1107275 · Cited by 28
Human Globin Knock-in Mice Complete Fetal-to-Adult Hemoglobin Switching in Postnatal Development
McConnell, S. C., Huo, Y., Liu, S., & Ryan, T. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00725-10 · Cited by 24
Venkatesan, V., Srinivasan, S., Babu, P., & Thangavel, S. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-20 · Cited by 26
Eaton, W. A. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100971 · Cited by 22
Haemoglobin and the Inherited Disorders of Globin Synthesis
Thein, S. L., & Rees, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118853771.ch6 · Cited by 28
Self-citationLIN28A Expression Reduces Sickling of Cultured Human Erythrocytes
de Vasconcellos, J. F., Fasano, R. M., Lee, Y. T., Kaushal, M., Byrnes, C., Meier, E. R., Anderson, M., Rabel, A., Braylan, R. C., Stroncek, D. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106924 · Cited by 23
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 25
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
Zittersteijn, H. A., Harteveld, C. L., Klaver-Flores, S., Lankester, A. C., Hoeben, R. C., Staal, F. J. T., & Gonçalves, M. A. F. V. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617780 · Cited by 24
Precision Medicine and Sickle Cell Disease
Hoss, S. E., Nemer, W. E., & Rees, D. C. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000762 · Cited by 21
Han, Y., Tan, X., Jin, T., Zhao, S., Li, H., Zhang, W., Kurita, R., Nakamura, Y., Liu, J., Li, D., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174788 · Cited by 21
A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing
Zheng, G., Yin, M., Mehta, S., Chu, I.-T., Wang, S., Alshaye, A., Drainville, K., Buyanbat, A., Bienfait, F., Tenglin, K., et al. (2024) · Science · doi:10.1126/science.adp3025 · Cited by 22
Exploring epigenetic and microRNA approaches for γ-globin gene regulation
Starlard‐Davenport, A., Fitzgerald, A., & Pace, B. S. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211028195 · Cited by 22
Lai, Y., Zhou, L., Yi, S., Chen, Y., Tang, Y., Yi, S., Yang, Z., Wei, H., Zheng, C., & he, S. T. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.01.011 · Cited by 22
Ali, G., Tariq, M. A., Shahid, K., Ahmad, F. J., & Akram, J. (2020) · Gene Therapy · doi:10.1038/s41434-020-0153-9 · Cited by 29
Genome-based therapeutic interventions for β-type hemoglobinopathies
Karamperis, K., Tsoumpeli, M. T., Kounelis, F., Koromina, M., Mitropoulou, C., Moutinho, C., & Patrinos, G. P. (2021) · Human Genomics · doi:10.1186/s40246-021-00329-0 · Cited by 21
What influences Hb fetal production in adulthood?
Carrocini, G. C. S., Zamaro, P. J. A., & Bonini-Domingos, C. R. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110059 · Cited by 26
Zhu, X., Hu, T., Ho, M. H., Wang, Y., Yu, M., Patel, N., Pi, W., Choi, J.-H., Xu, H., Ganapathy, V., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.175646 · Cited by 24
The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria
Ojewunmi, O. O., Adeyemo, T. A., Oyetunji, A. I., Inyang, B. A., Akinrindoye, A., Mkumbe, B. S., Gardner, K., Rooks, H., Brewin, J. N., Patel, H., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae014 · Cited by 20
Self-citationGoodman, S. R., Pace, B. S., Hansen, K. C., D’Alessandro, A., Xia, Y., Daescu, O., & Glatt, S. J. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216640150 · Cited by 21
Das, S. S., & Chakravorty, N. (2019) · Genomics · doi:10.1016/j.ygeno.2019.03.002 · Cited by 20
The Sub-Phenotypes of Sickle Cell Disease in Kuwait
Adekile, A. D., Al-Sherida, S., Marouf, R., Mustafa, N. Y., & Thomas, D. (2019) · Hemoglobin · doi:10.1080/03630269.2019.1610427 · Cited by 21
Urio, F., Nkya, S. W., Rooks, H., Mgaya, J., Masamu, U., Sangeda, R. Z., Mmbando, B. P., Brumat, M., Mselle, T., Menzel, S., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17102 · Cited by 19
Self-citationGenetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene
Mettananda, S. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.752278 · Cited by 20
Genetic and Epigenetic Mechanisms of β-Globin Gene Switching
Iarovaia, O. V., Kovina, A. P., Petrova, N. V., Razin, S. V., Ioudinkova, E. S., Vassetzky, Y. S., & Ulianov, S. V. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918040090 · Cited by 24
Haemoglobin and the Inherited Disorders of Globin Synthesis
Thein, S. L., & Rees, D. C. (2010) · Wiley eBooks · doi:10.1002/9781444323160.ch6 · Cited by 21
Self-citationIn The Blood: Connecting Variant to Function In Human Hematopoiesis
Nandakumar, S. K., Liao, X., & Sankaran, V. G. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.05.006 · Cited by 19
Wu, H., Huang, Q., Yu, Z., & Zhong, Z. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24105 · Cited by 18
Pecoraro, A., Rigano, P., Troia, A., Calzolari, R., Scazzone, C., Maggio, A., Steinberg, M. H., & Marzo, R. D. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12204 · Cited by 18
Mutation analysis of β-thalassemia in East-Western Indian population: a recent molecular approach
Shah, P. S., Shah, N. D., Ray, H. S. P., Khatri, N. B., Vaghasia, K. K., Raval, R. J., Shah, S. C., & Rao, M. V. (2017) · The Application of Clinical Genetics · doi:10.2147/tacg.s127531 · Cited by 18
BCL11A Down-Regulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells
Li, J., Yongrong, L., & Shi, L. (2018) · Hemoglobin · doi:10.1080/03630269.2018.1515774 · Cited by 20
BCL11A expression in acute myeloid leukemia
Tao, H., Ma, X., Su, G., Yin, J., Xie, X., Hu, C., Chen, Z., Tan, D., Xu, Z., Zheng, Y., et al. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.12.001 · Cited by 21
Estimation of the difference in HbF expression due to loss of the 5' -globin BCL11A binding region
Ghedira, E. S., Lecerf, L., Faubert, E., Costes, B., Moradkhani, K., Bachir, D., Galactéros, F., & Pissard, S. (2012) · Haematologica · doi:10.3324/haematol.2012.061994 · Cited by 17
Recent advances in globin research using genome‐wide association studies and gene editing
Orkin, S. H. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13001 · Cited by 17
Lai, Y., Chen, Y., Chen, B., Zheng, H., Yi, S., Li, G., Wei, H., he, S. T., & Zheng, C. (2016) · Hemoglobin · doi:10.1080/03630269.2016.1253586 · Cited by 18
Molecular simulation studies on B-cell lymphoma/leukaemia 11A (BCL11A).
AbdulAzeez, S. (2019) · Europe PMC (PubMed Central) · Cited by 20
Genomic architecture of sickle cell disease in West African children
Quinlan, J., Idaghdour, Y., Goulet, J.-P., Gbeha, E., de Malliard, T., Bruat, V., Grenier, J., Gomez, S., Sanni, A., Rahimy, M. C., et al. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00026 · Cited by 20
Cyrus, C., Vatte, C., Borgio, J. F., Al‐Rubaish, A. M., Chathoth, S., Naserullah, Z. A., Al‐Jarrash, S., Sulaiman, A., Qutub, H. O., Alsaleem, H., et al. (2017) · BioMed Research International · doi:10.1155/2017/1972429 · Cited by 19
Izumikawa, K., Ishikawa, H., Simpson, R. J., & Takahashi, N. (2018) · RNA Biology · doi:10.1080/15476286.2018.1465795 · Cited by 17
Pace, B. S., Perrine, S. P., Li, Y., Makala, L., Xu, H., Takezaki, M., Wolf, R. F., Wang, A., Xu, X., Huang, J., et al. (2021) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2021.102561 · Cited by 18
Effective therapies for sickle cell disease: are we there yet?
Crossley, M., Christakopoulos, G. E., & Weiss, M. J. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.07.003 · Cited by 22
Chami, N., & Lettre, G. (2014) · Genes · doi:10.3390/genes5010051 · Cited by 19
El-Ghamrawy, M., Yassa, M. E., Tousson, A. M. S., Elhady, M. A., Mikhaeil, E., Mohamed, N. B., & Khorshied, M. M. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04187-z · Cited by 18
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
Wessels, M. W., Cnossen, M. H., van Dijk, T. B., Gillemans, N., Schmidt, K. L. J., van Lom, K., Vinjamur, D. S., Coyne, S. M., Kurita, R., Nakamura, Y., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003753 · Cited by 16
Metadata
- Authors
- Menzel, S., Garner, C., Gut, I., Matsuda, F., Yamaguchi, M., Heath, S., Foglio, M., Zelenika, D., Boland, A., Rooks, H., Best, S., Spector, T. D., Farrall, M., Lathrop, M., & Thein, S. L.
- Affiliations
- King's College London (GB)
- University of California, Irvine (US)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- St Thomas' Hospital (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Thein, Swee Lay
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-09-02
- Volume
- 39
- Issue
- 10
- Pages
- 1197-1199
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2036308544
- Cited by
- 529
- References
- 16
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 22 · 2023: 27 · 2022: 24 · 2021: 34 · 2020: 43 · 2019: 25 · 2018: 33 · 2017: 27 · 2016: 37 · 2015: 27 · 2014: 25 · 2013: 26 · 2012: 20
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- fetal hemoglobin, F cells, quantitative trait loci, BCL11A, zinc finger proteins, sickle cell disease, beta-thalassemia, genome-wide association study
- MeSH terms
- Anemia, Sickle Cell, Carrier Proteins, Chromosome Mapping, Chromosomes, Human, Pair 2, Fetal Hemoglobin, Humans, Nuclear Proteins, Phenotype, Repressor Proteins, Genetic Variation, Genome, Human, Zinc Fingers, beta-Thalassemia, Quantitative Trait Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.